| |
| |
|
| Insider
Information: |
Chen Bihua |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
35,861,240 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$429,242,321 |
|
|
| Total
Shares |
35,861,240 |
|
|
| Total
Value |
$429,242,321 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
2
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
2
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
 -2.2%
|
-54.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clearside Biomedical, Inc. |
CLSD |
Director, 10% Owner |
|
0 |
2016-06-01 |
1,988,208 |
Premium* |
|
|
Kineta Ord Shs |
KA |
Director, 10% Owner |
|
0 |
2016-11-03 |
2,430,605 |
Premium* |
|
|
Turning Point Therapeutics, Inc. |
TPTX |
Director, 10% Owner |
2019-05-14 |
0 |
2019-05-14 |
3,122,367 |
Premium* |
|
|
Helix Acquisition Corp |
HLXA |
|
2020-10-22 |
0 |
2023-06-30 |
8,604,200 |
Premium* |
|
|
Erasca, Inc. |
ERAS |
Director |
2021-07-26 |
0 |
2021-08-10 |
10,505,553 |
Premium* |
|
|
Immuneering Corp |
IMRX |
|
|
0 |
2023-04-20 |
4,204,364 |
Premium* |
|
|
GreenLight Biosciences Holdings,... |
GRNA |
|
2023-07-20 |
0 |
2023-07-20 |
0 |
Premium* |
|
|
EyePoint Pharmaceuticals Inc |
EYPT |
|
|
0 |
2023-12-04 |
3,530,943 |
Premium* |
|
|
Corbus Pharmaceuticals Holdings,... |
CRBP |
|
2024-01-26 |
0 |
2024-02-02 |
1,475,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRBP |
Corbus Pharmaceuticals Ho... |
|
• • • |
2024-02-02 |
4 |
B |
$19.00 |
$14,250,000 |
I/I |
750,000 |
1,475,000 |
0.01 |
% |
|
| CRBP |
Corbus Pharmaceuticals Ho... |
|
– – • |
2024-01-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
442,368 |
|
% |
|
| CRBP |
Corbus Pharmaceuticals Ho... |
|
• • • |
2024-01-26 |
4 |
B |
$25.73 |
$9,111,941 |
I/I |
282,632 |
725,000 |
0.01 |
% |
|
| EYPT |
EyePoint Pharmaceuticals ... |
|
– – • |
2023-12-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,530,943 |
|
- |
|
| GRNA |
GreenLight Biosciences Ho... |
(See below) |
• • – |
2023-07-20 |
4 |
S |
$0.00 |
$0 |
I/I |
(9,188,659) |
0 |
0 |
% |
|
| HLXA |
Helix Acquisition Corp |
|
• • • |
2023-06-30 |
4 |
B |
$50.00 |
$40,000,000 |
I/I |
800,000 |
4,927,100 |
0.01 |
- |
|
| HLXA |
Helix Acquisition Corp |
|
• • • |
2023-06-26 |
4 |
B |
$36.91 |
$20,535,012 |
I/I |
450,000 |
4,127,100 |
0.01 |
- |
|
| IMRX |
Immuneering Corp |
|
– – • |
2023-04-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,204,364 |
|
- |
|
| HLXA |
Helix Acquisition Corp |
|
• • • |
2023-03-21 |
4 |
B |
$21.70 |
$5,175,999 |
I/I |
238,511 |
3,677,100 |
0.01 |
- |
|
| HLXA |
Helix Acquisition Corp |
|
• • • |
2023-03-20 |
4 |
B |
$19.36 |
$11,598,847 |
I/I |
588,589 |
3,438,589 |
0.01 |
- |
|
| HLXA |
Helix Acquisition Corp |
10% Owner |
– – • |
2022-04-05 |
4 |
B |
$10.00 |
$28,500,000 |
I/I |
2,850,000 |
2,850,000 |
1.5 |
- |
|
| HLXA |
Helix Acquisition Corp |
10% Owner |
– – • |
2022-04-05 |
4 |
A |
$0.00 |
$0 |
I/I |
2,785,000 |
3,215,000 |
0 |
- |
|
| ERAS |
Erasca, Inc. |
Director |
– • – |
2021-08-10 |
4 |
B |
$22.10 |
$4,420,000 |
I/I |
200,000 |
10,505,553 |
2.1 |
% |
|
| ERAS |
Erasca, Inc. |
Director |
– • – |
2021-07-26 |
4 |
S |
$18.77 |
$3,753,000 |
I/I |
(200,000) |
10,305,553 |
0 |
% |
|
| HLXA |
Helix Acquisition Corp |
CEO and Chairman |
• • • |
2020-10-22 |
4 |
B |
$10.00 |
$4,300,000 |
I/I |
430,000 |
430,000 |
2.64 |
% |
|
| TPTX |
Turning Point Therapeutic... |
Director |
– • • |
2019-05-14 |
4 |
OE |
$2.19 |
$51,062 |
I/I |
23,268 |
3,122,367 |
0 |
- |
|
| KA |
Kineta Ord Shs |
Director |
– • • |
2016-11-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,430,605 |
|
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2016-06-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,988,208 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
